Month: September 2012

Whole-genome scan can help doctors choose best treatment option for children with neuroblastoma

A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London. The researchers called for all children diagnosed with neuroblastoma worldwide to have a whole-genome scan as a standard […]

read more